Loading...
XASX
ADR
Market cap7mUSD
Jul 11, Last price  
0.01AUD
1D
20.00%
1Q
-33.33%
Jan 2017
-99.83%
IPO
-99.94%
Name

Adherium Ltd

Chart & Performance

D1W1MN
P/E
P/S
12.82
EPS
Div Yield, %
Shrs. gr., 5y
100.02%
Rev. gr., 5y
-21.26%
Revenues
841k
-73.68%
559,525480,9332,907,0002,100,8002,347,0005,867,0002,779,0002,218,000401,000529,0003,195,000840,982
Net income
-10m
L+3.71%
-138,506-2,206,911-1,255,000-6,308,000-12,810,000-9,338,000-11,794,000-11,397,000-15,036,000-10,044,000-9,858,000-10,224,173
CFO
-11m
L+14.39%
0-2,161,61123,000-7,913,000-11,581,000-9,824,000-11,807,000-7,317,000-11,273,000-9,610,000-9,278,000-10,613,012
Earnings
Jul 28, 2025

Profile

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. The company offers Hailie, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around a patient's inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal. The company was incorporated in 2001 and is based in Auckland, New Zealand.
IPO date
Aug 26, 2015
Employees
Domiciled in
NZ
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
841
-73.68%
3,195
503.97%
Cost of revenue
11,918
15,088
Unusual Expense (Income)
NOPBT
(11,077)
(11,893)
NOPBT Margin
Operating Taxes
(1,450)
(1,838)
Tax Rate
NOPAT
(9,626)
(10,055)
Net income
(10,224)
3.71%
(9,858)
-1.85%
Dividends
Dividend yield
Proceeds from repurchase of equity
7,729
12,327
BB yield
-115.69%
-120.77%
Debt
Debt current
47
44
Long-term debt
139
44
Deferred revenue
Other long-term liabilities
11
Net debt
(6,011)
(8,989)
Cash flow
Cash from operating activities
(10,613)
(9,278)
CAPEX
(37)
(41)
Cash from investing activities
(37)
(41)
Cash from financing activities
7,729
13,071
FCF
(9,832)
(9,898)
Balance
Cash
6,198
9,077
Long term investments
Excess cash
6,155
8,917
Stockholders' equity
6,480
9,214
Invested Capital
429
341
ROIC
ROCE
EV
Common stock shares outstanding
371,139
272,205
Price
0.02
-52.00%
0.04
-64.29%
Market cap
6,681
-34.55%
10,207
-32.92%
EV
669
1,218
EBITDA
(11,077)
(11,702)
EV/EBITDA
Interest
2
Interest/NOPBT